|
1
|
Heerspink HJ, Perkins BA and Fitchett D:
Sodium-glucose cotransporter 2 inhibitors in the treatment of
diabetes mellitus: Cardiovascular outcomes and kidney disease.
Lancet. 396:1239–1253. 2020.
|
|
2
|
Mocco J, Ransom ER, Komotar RJ, Schmidt
JM, Sciacca RR, Mayer SA and Connolly ES Jr: Preoperative
prediction of long-term outcome in poor-grade aneurysmal
subarachnoid hemorrhage. Neurosurgery. 59:529–538. 2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
https://www.ninds.nih.gov/health-information/disorders/cerebral-aneurysms.
|
|
4
|
Wiebers DO, Whisnant JP, Huston J III,
Meissner I, Brown RD Jr, Piepgras DG, Forbes GS, Thielen K, Nichols
D, O'Fallon WM, et al: Unruptured intracranial aneurysms: Natural
history, clinical outcome, and risks of surgical and endovascular
treatment. Lancet. 362:103–110. 2003.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Pepin M, Schwarze U, Superti-Furga A and
Byers PH: Clinical and genetic features of Ehlers-Danlos syndrome
type IV, the vascular type. N Engl J Med. 342:673–680.
2000.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kielty CM, Sherratt MJ and Shuttleworth
CA: Elastic fibres. J Cell Sci. 115:2817–2828. 2002.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhang B, Henney A, Eriksson P, Hamsten A,
Watkins H and Ye S: Genetic variation at the matrix
metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet.
105:418–423. 1999.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Liu W, Morito D, Takashima S, Mineharu Y,
Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda
A, et al: Identification of RNF213 as a susceptibility gene for
moyamoya disease and its possible role in vascular development.
PLoS One. 6(e22542)2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
American Diabetes Association Professional
Practice Committee. 6. Glycemic targets: Standards of medical care
in diabetes-2022. Diabetes Care. 45 (Suppl 1):S83–S96.
2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ganesh J and Viswanathan V: Management of
diabetic hypertensives. Indian J Endocrinol Metab. 15 (Suppl
4):S374–S379. 2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
SCORE2 risk prediction algorithms. new
models to estimate 10-year risk of cardiovascular disease in
Europe. Eur Heart J. 42:2439–2454. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
American Diabetes Association Professional
Practice Committee. 10. Cardiovascular disease and risk management:
Standards of care in diabetes-2024. Diabetes Care. 47 (Suppl
1):S179–S218. 2024.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chalouhi N, Jabbour P and Tjoumakaris SI:
Cerebral aneurysms: Pathogenesis, diagnosis, and treatment. J
Neurosurg. 118:845–856. 2013.
|
|
14
|
Karsdal MA, Krarup H, Sand JMB,
Christensen PB, Gerstoft J, Leeming DJ, Weis N, Schaffalitzky de
Muckadell OB and Krag A: Review article: the efficacy of biomarkers
in chronic fibroproliferative diseases-early diagnosis and
prognosis, with liver fibrosis as an exemplar. Aliment Pharmacol
Ther. 40:233–249. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li J, Liu S, Li W, Hu S, Xiong J, Shu X,
Hu Q, Zheng Q and Song Z: Vascular smooth muscle cell apoptosis
promotes transplant arteriosclerosis through inducing the
production of SDF-1α. Am J Transplant. 12:2029–2043.
2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chen B, Lu Y, Chen Y and Cheng J: The role
of Nrf2 in oxidative stress-induced endothelial injuries. J
Endocrinol. 225:R83–R99. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sanchez Corredera C, Tadepalli PS, Scaccia
J, Sibia AS and Mayrovitz HN: Implications of long sleep duration
on cardiovascular health: A systematic review. Cureus.
17(e77738)2025.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Neumiller JJ, Alicic RZ and Tuttle KR:
Therapeutic considerations for antihyperglycemic agents in diabetic
kidney disease. J Am Soc Nephrol. 28:2263–2274. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Vasilenko LA and Zotov VV: Digitalization
of public administration in Russia: Risks, casuses, problems. Digit
Sociol. 3:4–16. 2020.(In Russian).
|
|
20
|
Liu Z, Ren Z, Zhang J, Chuang CC,
Kandaswamy E, Zhou T and Zuo L: Role of ROS and nutritional
antioxidants in human diseases. Front Physiol.
9(477)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Dunn SR and St. John L: The impact of
SGLT2 inhibitors on endothelial function and vascular health: A
review. Vasc Pharmacol. 117:29–37. 2019.
|
|
22
|
Cherney DZ, Prestidge RL and Qiu W:
Effects of sodium-glucose cotransporter 2 inhibitors on kidney
function and proteinuria: A review of the mechanisms and clinical
effects. Can J Diabetes. 42:278–283. 2018.
|
|
23
|
Amzolini AM, Forțofoiu MC, Alhija AB,
Vladu IM, Clenciu D, Mitrea A, Forțofoiu M, Matei D, Diaconu M,
Tudor MS and Micu ES: Triglyceride and glucose index as a screening
tool for nonalcoholic liver disease in patients with metabolic
syndrome. J Clin Med. 11(3043)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Amzolini AM, Forţofoiu MC, Barău
Abu-Alhija A, Vladu IM, Clenciu D, Mitrea A, Forţofoiu M, Matei D,
Enăchescu V, Predescu OI and Micu ES: Triglyceride and glucose
index: A useful tool for non-alcoholic liver disease assessed by
liver biopsy in patients with metabolic syndrome? Rom J Morphol
Embryol. 62:475–480. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yaribeygi H, Maleki M, Jamialahmadi T,
Moallem SA and Sahebkar A: Hepatic benefits of sodium-glucose
cotransporter 2 inhibitors in liver disorders. EXCLI J. 22:403–414.
2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Pawlos A, Broncel M, Woźniak E and
Gorzelak-Pabiś P: Neuroprotective effect of SGLT2 inhibitors.
Molecules. 26(7213)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jin Z, Deng H, Xiong S and Gao L:
Perspective of SGLT2i in the treatment of abdominal aortic
aneurysms. J Cardiovasc Pharmacol. 81:241–247. 2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Liu Y, Wu M, Xu B and Kang L:
Empagliflozin alleviates atherosclerosis progression by inhibiting
inflammation and sympathetic activity in a normoglycemic mouse
model. J Inflamm Res. 14:2277–2287. 2021.PubMed/NCBI View Article : Google Scholar
|
